Treatment of respiratory depression with the anticholinesterase drug galanthamine hydrobromide.
D000328:Adult; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003916:Dextromoramide / Q000506:poisoning; D004155:Diphenhydramine / Q000506:poisoning; D004338:Drug Combinations; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008702:Methaqualone / Q000506:poisoning; D012131:Respiratory Insufficiency / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy
D002800:Cholinesterase Inhibitors; D004338:Drug Combinations; D005702:Galantamine; D008702:Methaqualone; D004155:Diphenhydramine; D003916:Dextromoramide